Using AI, scientists find a drug that could combat drug-resistant infections
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings.
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings.
Fifteen principal investigators from across MIT will conduct early work to solve issues ranging from water contamination to aquaculture monitoring and management.
The Fulbright US Student Program funds opportunities for research, graduate study, and teaching abroad.
A cancer vaccine combining checkpoint blockade therapy and a STING-activating drug eliminates tumors and prevents recurrence in mice.
Matt Shoulders will lead an interdisciplinary team to improve RuBisCO — the photosynthesis enzyme thought to be the holy grail for improving agricultural yield.
MIT engineers’ new technique analyzes the 3D organization of the genome at a resolution 100 times higher than before.
Ahead of the Institute’s presidential inauguration, panelists describe advances in their research and how these discoveries are being deployed to benefit the public.
Faculty and researchers across MIT’s School of Engineering receive many awards in recognition of their scholarship, service, and overall excellence.
Fellowship funds graduate studies for outstanding immigrants and children of immigrants.
The award recognizes exceptional distinction in teaching, research, and service at MIT.
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
With sustainability in mind, MIT’s EHS Lab Plastics Recycling Program gathers clean plastics from 212 MIT labs, recycling some 280 pounds per week.
Senior Victor Damptey brings his Spanish-speaking abilities to bear as he works toward becoming a physician-scientist.
With further development, the programmable system could be used in a range of applications including gene and cancer therapies.
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.